Ramser, Michaela
Eichelberger, Simone
Däster, Silvio
Weixler, Benjamin
Kraljević, Marko
Mechera, Robert
Tampakis, Athanasios
Delko, Tarik
Güth, Uwe
Stadlmann, Sylvia
Terracciano, Luigi
Droeser, Raoul A.
Singer, Gad
Funding for this research was provided by:
Oncosuisse (OCS 01506-02-2004)
Article History
Received: 18 November 2017
Accepted: 8 April 2018
First Online: 16 April 2018
Ethics approval and consent to participate
: This study was approved by the regional ethics committee of the University Hospital Basel Switzerland. Finally, the study was performed according to the guidelines of the institutional review boards (IRB) of the participating institutions as previously published [CitationRef removed–CitationRef removed]. The need for patient consent for studies using this TMA was originally waived by the ethics committee of northwestern Switzerland (EKNZ). Currently the TMA is handed at the biobank of th Institute of Pathology of the University Hospital Basel.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.